XM does not provide services to residents of the United States of America.

Puig to join Spain's blue-chip index two months after IPO



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Puig to join Spain's blue-chip index two months after IPO</title></head><body>

By Corina Pons and Matteo Allievi

MADRID, July 9 (Reuters) -Puig PUIGb.MC will join Spain's blue-chip equities index on July 22, the stock market's advisory committee said on Tuesday, just over two months after the cosmetics company completed the country's biggest initial public offering in nearly a decade.

Puig will replace Melia Hotels MEL.MC in the IBEX 35 .IBEX index.

Puig's share price has risen more than 3% since its market debut, in part as investors bet the owner of Rabanne and Carolina Herrera perfumes would join indexes such as the IBEX, which until now has lacked a major luxury presence.

Its shares were last trading at 25.35 euros, valuing the company at more than 14 billion euros ($15 billion).

Puig went public after buying brands such as luxury label Byredo and Charlotte Tilbury make-up in recent years to better compete with rivals L'Oreal OREP.PA and Estee Lauder EL.N.

Its in-house brands such as Rabanne brought in net revenues of more than 1 billion euros in 2023, with Jean Paul Gaultier showing the fastest growth within the portfolio.

In its first note on Puig, JP Morgan forecast the company would benefit from strong demand for premium perfumes as well as make-up and skincare, and said the shares could reach 32 euros apiece by December 2025.

The Barcelona-based company, in which the Puig family retains a majority stake, posted a 10.1% year-on-year increase in net sales in the first quarter of 2024, outpacing the wider premium beauty market.

Bank of America and JP Morgan expect Puig's sales to continue to grow ahead of listed peers. They also see opportunities for mergers and acquisitions as Puig has said proceeds from its IPO would help fund investments.

($1 = 0.9240 euros)



Reporting by Corina Pons and Matteo Allievi; Editing by David Latona and Mark Potter

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.